Topic:

Partnering

Latest Headlines

Latest Headlines

SomaLogic, CO hospital to develop biomarkers/Dx tests for childhood diseases

Two Colorado entities are joining forces in an industry-academic diagnostic and biomarker partnership: Children's Hospital Colorado and SomaLogic, a 14-year-old life science tools and clinical diagnostics company.

Novartis taps Oxford BioMedica in $90M immuno-oncology deal

Novartis has expanded its relationship with the U.K.'s Oxford BioMedica, signing a deal worth up to $90 million that will support the drugmaker's efforts in CAR-T immunotherapies.

Wellcome Trust, Merck Serono collaborate on cancer drug discovery

Merck Serono is teaming up with London's Institute of Cancer Research and the charitable Wellcome Trust to identify and develop new inhibitors to treat cancer.

Bellicum puts up $50M for Ariad's R&D tech

Bellicum Pharmaceuticals has switched up its deal with Ariad Pharmaceuticals, agreeing to hand over $50 million for a no-strings-attached license to some cell-signaling technology.

Unilife inks 15-year deal with Sanofi for wearable injectors

Unilife, the injectable technology provider, has inked a deal with Sanofi to be the French drugmaker's sole provider of cartridge-based wearable injectors for the next 15 years.

Baxter backs Rockwell with a $45M hemodialysis deal

Kidney drug developer Rockwell Medical picked up a big co-sign from a leader in the space, signing a deal with Baxter International that will help pay the way for its late-stage iron-delivery treatment.

Boehringer pilots inhalers with sensors to encourage patient adherence

Boehringer Ingelheim envisions some day selling day a smart inhaler that can tell patients when its medication is running low and remind them if they missed a prescheduled dose. 

Microsoft, Aerocrine partner to send asthma device data to the cloud

Aerocrine has partnered with Microsoft in a pilot project to send data from nitric oxide monitoring devices to the cloud for analysis.

Post-IPO Ergomed keeps rolling with its risk-sharing partnerships

U.K. drug development outfit Ergomed has come out the other end of its London IPO, touting a range of R&D partnerships that give it a chance to share the rewards of its clients' work.

Catalent partners up with Cingulate on two ADHD drugs

The recently IPO'd Catalent has signed a deal with biotech Cingulate Therapeutics to help develop a duo of candidates for ADHD, tapping its expertise in crafting controlled-release tablets.